Potassium для Cardiac Arrhythmia

C Доказательства Доказательства ограничены небольшими исследованиями, однако имеются некоторые положительные сигналы.

Hypokalemia is a well-established arrhythmia trigger. Guidelines support maintaining serum K+ >4.0 mEq/L. Research on supplementation benefit in normokalemic patients is unclear.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dpotassium\u0026condition\u003Darrhythmia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Итог

Hypokalemia is a well-established arrhythmia trigger. Guidelines support maintaining serum K+ >4.0 mEq/L. Research on supplementation benefit in normokalemic patients is unclear.

Key Study Findings

Other n=19 1 weeks

Effect of moderate potassium-elevating treatment in long QT syndrome: the TriQarr Potassium Study.

Dose: 50 mg или: baseline Outcome: cardiac repolarisation Эффект: None p=0.07

Популяция: lqts with a disease-causing kcnq1 or kcnh2 variant

Cohort Study n=157766 26.0 weeks

Elevated potassium levels in patients with chronic kidney disease: occurrence, risk factors and clinical outcomes-a …

Dose: None или: None Outcome: Incidence of hyperkalemia, mortality Эффект: None None

Популяция: Newly diagnosed CKD patients in Denmark

Observational Study n=40

Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1).

Dose: anti-digoxin antibodies (Fab) или: pre-treatment Outcome: serum digoxin and clinical outcomes Эффект: Fab bound digoxin; no improved clinical outcomes None

Популяция: Chronic digoxin toxicity patients

Other

Abbott ARCHITECT clinical chemistry and immunoassay systems: digoxin assays are free of interferences from spironolactone, …

Dose: None или: None Outcome: None Эффект: None None

Популяция: None

Other

Potassium supplements or potassium-sparing agents.

Dose: None или: None Outcome: mineral status Эффект: None None

Популяция: hypertensive patients

Key Statistics

Исследования

300

Участники

↑

Positive

Оценка

Referenced Papers

Effect of moderate potassium-elevating treatment in long QT syndrome: the TriQarr Potassium Study. Other

Open heart 2021 6 цитирований

Elevated potassium levels in patients with chronic kidney disease: occurrence, risk factors and clinical outcomes-a Danish population-based cohort study. Other

Nephrology, dialysis, transplantation … 2018 83 цитирований

Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1). Observational

Clinical toxicology (Philadelphia, … 2016 25 цитирований

Abbott ARCHITECT clinical chemistry and immunoassay systems: digoxin assays are free of interferences from spironolactone, potassium canrenoate, and their common … Other

Therapeutic drug monitoring 2011 17 цитирований

Potassium supplements or potassium-sparing agents. Other

Acta pharmacologica et … 1984 3 цитирований

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Часто используемые дозировки

supplements:: Typically 99 mg/dose (FDA limit per unit)
dashdiettarget:: 4,700 mg/day
whorecommendation:: 3,510 mg/day from food

Верхний предел: No UL for dietary potassium in healthy individuals; supplemental potassium should be supervised

Дозировки, изученные в исследованиях

Дозировка	Длительность	Эффект	N
50 mg	1 weeks	Neutral	19
None	26.0 weeks	Mixed	157766
anti-digoxin antibodies (Fab)	--	Neutral	40
None	--	Positive	--
None	--	Mixed	--

Лучшее время приёма: With meals to reduce GI irritation; divide supplemental doses throughout the day

Safety & Side Effects

Зарегистрированные побочные эффекты

⚠ Gastrointestinal irritation (nausea, vomiting, diarrhea)
⚠ Hyperkalemia risk in patients with renal impairment
⚠ Cardiac arrhythmias at excessively high serum levels

Известные взаимодействия

● ACE inhibitors (increased hyperkalemia risk)
● ARBs (increased hyperkalemia risk)
● Potassium-sparing diuretics (increased hyperkalemia risk)
● NSAIDs (may increase potassium retention)

Допустимый верхний уровень потребления: No UL for dietary potassium in healthy individuals; supplemental potassium should be supervised

Всегда консультируйтесь с врачом перед началом приёма любых добавок.Всегда консультируйтесь с лечащим врачом перед началом приёма любой добавки.

Frequently Asked Questions

Does Potassium help with Cardiac Arrhythmia?

Based on 5 studies with 300 participants, there is limited but promising evidence that Potassium may support Cardiac Arrhythmia management. Our evidence grade is C (Some Evidence).

How much Potassium should I take for Cardiac Arrhythmia?

Studies have used various dosages. A commonly studied range is Typically 99 mg/dose (FDA limit per unit). Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Potassium?

Reported side effects may include Gastrointestinal irritation (nausea, vomiting, diarrhea), Hyperkalemia risk in patients with renal impairment, Cardiac arrhythmias at excessively high serum levels. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Potassium and Cardiac Arrhythmia?

We rate the evidence as Grade C (Some Evidence). This rating is based on 5 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.

Другие ингредиенты для Cardiac Arrhythmia

Omega-3 Fatty Acids (EPA/DHA) B Magnesium B Coenzyme Q10 (CoQ10) C

Potassium для других состояний

High Blood Pressure (Hypertension) B

Краткий вывод

Hypokalemia is a well-established arrhythmia trigger. Guidelines support maintaining serum K+ >4.0 mEq/L. Research on supplementation benefit in normokalemic patients is unclear.

Evidence Strength52%

Moderate confidence

Разбор исследований

RCT (0)Meta (0)Other (5)

Сравнить альтернативы

Узнайте, как другие ингредиенты сравниваются при данном состоянии.

Посмотреть все ингредиенты для Cardiac Arrhythmia

Узнать больше

References

[1] Peter Marstrand et al.. Open Heart. 2021. Effect of moderate potassium-elevating treatment in long QT syndrome: the TriQarr Potassium Study. doi:10.1136/openhrt-2021-001670 PubMed
[2] Reimar W Thomsen et al.. Nephrol Dial Transplant. 2018. Elevated potassium levels in patients with chronic kidney disease: occurrence, risk factors and clinical outcomes-a Danish population-based cohort study. doi:10.1093/ndt/gfx312 PubMed
[3] Betty S Chan et al.. Clin Toxicol (Phila). 2016. Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1). doi:10.1080/15563650.2016.1175620 PubMed
[4] Andrea DeFrance et al.. Ther Drug Monit. 2011. Abbott ARCHITECT clinical chemistry and immunoassay systems: digoxin assays are free of interferences from spironolactone, potassium canrenoate, and their common … doi:10.1097/FTD.0b013e3181fd4c30 PubMed
[5] S Persson. Acta Pharmacol Toxicol (Copenh). 1984. Potassium supplements or potassium-sparing agents. doi:10.1111/j.1600-0773.1984.tb03642.x PubMed

Отказ от ответственности FDA: Данные утверждения не были оценены Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов (FDA). Продукты и информация на этом сайте не предназначены для диагностики, лечения, излечения или профилактики каких-либо заболеваний. Представленные оценки доказательности основаны на нашем анализе опубликованных рецензируемых исследований и не являются медицинской консультацией. Всегда консультируйтесь с лечащим врачом перед началом приёма любых добавок.

Potassium для Cardiac Arrhythmia

Embed This Widget

Итог

Key Study Findings

Key Statistics

Referenced Papers

Dosage & Usage

Часто используемые дозировки

Дозировки, изученные в исследованиях

Safety & Side Effects

Зарегистрированные побочные эффекты

Известные взаимодействия

Frequently Asked Questions

Related Evidence

Другие ингредиенты для Cardiac Arrhythmia

Potassium для других состояний

References